+46.1%
GSK vs INVH
-9.7%
+55.8%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | INVH | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.1% | +0.1% | 0.0% |
| 7D | -3.5% | -3.0% | -0.5% | -2.7% |
| 30D | -3.4% | -7.5% | +4.1% | -1.3% |
| 3M | -8.1% | -5.5% | -2.6% | -6.7% |
| 6M | -11.1% | +11.7% | -22.8% | -13.6% |
| YTD | +0.7% | +1.3% | -0.6% | +0.2% |
| 1Y | +20.1% | -6.1% | +26.2% | +21.9% |
| 3Y | +46.1% | -9.8% | +55.9% | +52.1% |
| All | +46.1% | -9.7% | +55.8% | +52.1% |
Cumulative growth
Daily Returns
Daily percentage return beside INVH.
Daily Out/Under-Performance
Portfolio return minus INVH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INVH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded INVH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling